Prion Misfolding and Propagation

The Mechanism of Templated Misfolding

The prion protein, PrP-C, is a normal cell-surface protein found in abundance on neurons and, to a lesser extent, other cell types. In its native conformation it is rich in alpha-helical structure, a coiled shape that is soluble and readily broken down by cellular enzymes. The pathogenic form, PrP-Sc, is built from the same amino acid sequence but folds instead into a beta-sheet-rich structure. This is the critical point: no change in the genetic code or amino acid sequence is required to create PrP-Sc, only a change in three-dimensional shape. Beta-sheet-rich proteins tend to stack efficiently against one another, and PrP-Sc exploits this property by binding directly to normal PrP-C molecules at their surface. Once bound, the misfolded template appears to lower the energy barrier for the normal protein to refold, essentially dragging it into the same aberrant conformation. The newly converted molecule detaches, or remains part of a growing fibril, and is now itself capable of converting further PrP-C molecules. This is why prion propagation is described as autocatalytic: the product of the reaction is also its catalyst. Structural biologists studying this process describe it using the language of nucleated polymerization, borrowed from crystal growth. A stable 'seed' of misfolded protein must first form or be introduced, a slow and often rare event, but once that seed exists, growth by addition of new monomers is comparatively fast. This two-phase kinetic pattern — a lag phase followed by rapid exponential growth — is a hallmark of prion behavior and explains why prion diseases can have long, silent incubation periods followed by a period of rapid clinical decline.

From Sporadic Origins to Infectious Spread

Prion diseases arise through three distinct routes, and this variety is part of what made them so puzzling to early researchers. The sporadic form, exemplified by classic Creutzfeldt-Jakob disease, appears to begin with a rare, spontaneous misfolding event: by chance, a single PrP-C molecule in the brain flips into the PrP-Sc conformation and, against long odds, forms a stable seed rather than being degraded. The inherited form arises when a mutation in the PRNP gene alters the protein sequence in a way that makes the alpha-helical fold less stable and the beta-sheet fold more energetically favorable, dramatically raising the likelihood of spontaneous conversion. The acquired, or infectious, form is the one that captured public attention during the bovine spongiform encephalopathy, or 'mad cow disease', outbreak of the 1980s and 1990s, in which cattle feed contaminated with prion-infected tissue transmitted disease within herds, and in a small number of human cases, to people who consumed contaminated beef, causing variant Creutzfeldt-Jakob disease. What unites all three routes is that once a seed exists, by whatever means it arose, the downstream propagation mechanism is identical: templated conversion, chain reaction, and progressive accumulation of misfolded aggregates in neural tissue. This shared endpoint is why prion diseases are classified together despite their very different origins, and why researchers now use the term 'prion-like' to describe the behavior of other aggregating proteins that spread within the brain by a similar seeded mechanism, even when those proteins are not classically infectious between individuals.

Why Prions Resist Destruction

One of the most alarming properties of PrP-Sc is its extraordinary resistance to the methods that normally neutralize infectious agents. Conventional pathogens like bacteria and viruses carry nucleic acid genomes that can be destroyed by heat, radiation, or chemical treatment, rendering them harmless even if some protein structure survives. Prions carry no genetic material at all — the infectious agent is the misfolded protein itself, and that protein's dense, tightly packed beta-sheet structure is remarkably stable. Standard autoclave sterilization, which reliably kills bacteria, fungi, and most viruses, can fail to fully inactivate prions, and standard chemical disinfectants like alcohol and formaldehyde are largely ineffective against them. This resistance has real consequences for medicine: it has driven changes in surgical instrument sterilization protocols, especially for neurosurgery, and has restricted certain practices in tissue and blood donation. The structural basis for this resistance lies in how proteases, the enzymes that normally chop up misfolded or damaged proteins for recycling, interact with PrP-Sc. Proteases typically need to grab an exposed, flexible region of a protein to begin cutting it apart, but the compact, stacked beta-sheet architecture of PrP-Sc aggregates leaves few such vulnerable regions exposed. The result is a protein fragment, called PrP 27-30 after partial protease digestion, that remains infectious and stable even after treatment that would destroy nearly any other biological molecule. Only extreme measures, such as prolonged exposure to concentrated sodium hydroxide or very high temperature autoclaving well beyond standard settings, reliably inactivate it.

Clinical Presentation and the Spongiform Signature

As misfolded PrP-Sc accumulates within neurons and in the surrounding neuropil, it triggers a cascade of cellular dysfunction that eventually kills the affected cells. Under the microscope, brain tissue from a prion disease patient reveals a distinctive pattern: numerous small, round vacuoles, or holes, scattered throughout the gray matter, giving the tissue a sponge-like appearance that gives these diseases their formal name, the transmissible spongiform encephalopathies. Alongside this vacuolation, pathologists typically see reactive astrocytosis, a proliferation of support cells responding to neuronal injury, and in some forms, visible plaques of aggregated PrP-Sc similar in appearance to the amyloid plaques of Alzheimer's disease. Clinically, this translates into a rapidly progressive dementia, often accompanied by myoclonus, or sudden involuntary muscle jerks, visual disturbances, and coordination problems as the cerebellum becomes involved. Unlike most neurodegenerative diseases, which unfold over a decade or more, sporadic Creutzfeldt-Jakob disease typically kills within a matter of months from the first clear symptoms, a devastating speed that reflects the exponential nature of the underlying chain reaction once it reaches clinically significant levels. Diagnosis during life has historically been difficult, relying on a combination of clinical presentation, characteristic patterns on MRI, electroencephalogram abnormalities, and more recently, a highly sensitive laboratory test called real-time quaking-induced conversion, which exploits the very seeding mechanism responsible for the disease: it mixes a patient's cerebrospinal fluid with normal recombinant PrP-C and watches, in real time, whether any misfolded seed present in the sample can template detectable aggregation.

The Discovery That Rewrote Biology's Central Dogma

For much of the twentieth century, biology operated under an assumption so fundamental it was rarely stated outright: infectious agents replicate using nucleic acid, whether DNA or RNA, because information transfer requires a template made of nucleotides. When Stanley Prusiner began studying scrapie, a mysterious degenerative disease of sheep, in the 1970s, the infectious agent he was chasing stubbornly resisted every method known to destroy nucleic acids, while remaining just as infectious as ever. In 1982 Prusiner proposed a radical explanation: the infectious agent was 'proteinaceous' only, with no nucleic acid component at all, and he coined the term prion, short for 'proteinaceous infectious particle', to describe it. The idea was met with deep skepticism, even hostility, from much of the scientific community, since it appeared to violate the principle that biological information could only be transmitted through nucleic acid templates. Over the following fifteen years, accumulating structural, biochemical, and genetic evidence — including the demonstration that mice genetically engineered to lack the PrP gene entirely could not be infected with scrapie — steadily built the case in Prusiner's favor. He was awarded the Nobel Prize in Physiology or Medicine in 1997 for this work, a recognition that formally established protein-only conformational templating as a legitimate mechanism of biological information transfer. The implications reached far beyond prion disease itself: researchers now recognize that self-templating protein misfolding, once considered a biological curiosity unique to prions, is in fact a shared mechanistic thread running through Alzheimer's disease, Parkinson's disease, and several other neurodegenerative conditions, even though those diseases are not classically transmissible between individuals in the way prion diseases can be.

Frequently asked questions

Try it live

Everything above runs in your browser — open Prion Misfolding and Propagation and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.